The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

LIVE MARKETS-Taper Tantrum? Not just yet

Fri, 15th Jan 2021 07:52

* European stock futures down 0.5%

*

Jan 15 - Welcome to the home for real-time coverage of
markets brought to you by Reuters reporters. You can share your
thoughts with us at markets.research@thomsonreuters.com

TAPER TANTRUM? NOT JUST YET (0748 GMT)

Finally, markets have the news they've been waiting days
for: U.S. President-elect Joe Biden is proposing a $1.9 trillion
stimulus plan to jump-start the world's largest economy and
accelerate its response to COVID-19.

This is at the upper end of expectations. But in a
buy-the-rumour, sell-the-fact reaction, equities have eased a
touch and U.S. Treasury yields, which have shot higher on belief
that a big fiscal package will boost inflation, are also off
recent highs.

And for those looking for a taper tantrum, Federal Reserve
Chair Jerome Powell is not buying it, saying late on Thursday it
was too early for the Fed to adjust its monthly bond purchases.

His comments have paused a rally in the dollar for now.
Elsewhere, Bitcoin is recovering after a nearly $12,000 plunge
from the record $42,000 hit last week.

Concern over rising COVID-19 cases in China and signs of
fresh strains with Washington may also explain signs of caution
in markets. Executives of state-owned enterprises, officials of
the Chinese Communist Party and military, and oil giant CNOOC
will face new restrictions from the Trump
administration for allegedly using coercion against states with
rival South China Sea claims.

In Europe, political uncertainty in Italy remains in focus
although a snap election is still viewed as unlikely. Focus also
turns to Germany, where chancellor Angela Merkel's Christian
Democratic Union party on Saturday votes for a new leader and
will be a likely contender for next Chancellor.

Shares in German software group SAP are up 2% in
pre-market trade after preliminary annual results came at the
high end of guidance.

JP Morgan, Citigroup and Wells Fargo
report fourth-quarter results. Expectations are for financials
earnings to have dropped more than 6% but that's better than
what's forecast for the S&P 500 overall.

Key developments that should provide more direction to
markets on Friday:

- UK economy shrinks 2.6% in Nov, first drop since April.

- Italy's Renzi does not believe PM Conte has backing to win
no-confidence vote - La Stampa.

- U.S. retail sales, PPI 1330 GMT

- Fitch to review UK credit rating

- An emerging market rally lifted assets under management
(AUM) at money manager Ashmore by 9% in Q4

(Dhara Ranasinghe)

*****

EUROPE IN THE RED ON BIDEN’S CHALLENGES, PANDEMIC

European stock futures are in the red as markets focus on
the challenges U.S. president-elect Joe Biden will face in
getting approved a $1.9 trillion stimulus package, while
pandemic concerns continue to weigh on sentiment.

Investors are also concerned about possible tax increases
they expect to be part of Biden’s future plans.

China reporting the highest number of COVID-19 cases in more
than 10 months on Friday, with more than 28 million people under
lockdown, is dampening risk-appetite across the board.

(Stefano Rebaudo)

*****

Related Shares

More News
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was ...

7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.